Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 976 AL 990

Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer's-type dementia therapies

Jicha GA, Tucker TC, Arnold SM, Nelson PT.

Alzheimers Res Ther. 2024 Aug 21;16(1):184. doi: 10.1186/s13195-024-01532-6.

Case Definition for Diagnosed Alzheimer Disease and Related Dementias in Medicare

Gianattasio KZ, Wachsmuth J, Murphy R, Hartzman A, Montazer J, Cutroneo E, Wittenborn J, Power MC, Rein DB.

JAMA Netw Open. 2024 Sep 3;7(9):e2427610. doi: 10.1001/jamanetworkopen.2024.27610.

MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy

Li YB, Fu Q, Guo M, Du Y, Chen Y, Cheng Y.

Transl Psychiatry. 2024 Sep 10;14(1):367. doi: 10.1038/s41398-024-03075-8.

Morphometry of medial temporal lobe subregions using high-resolution T2-weighted MRI in ADNI3: Why, how, and what's next?

Yushkevich PA, Ittyerah R, Li Y, Denning AE, Sadeghpour N, Lim S, McGrew E, Xie L, DeFlores R, Brown CA, Wisse LEM, Wolk DA, Das SR; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Nov;20(11):8113-8128. doi: 10.1002/alz.14161. Epub 2024 Sep 16.

Alzheimer Disease: Treatment of Cognitive and Functional Symptoms

Jaqua EE, Tran MN, Hanna M.

Am Fam Physician. 2024 Sep;110(3):281-293.

AI-driven innovations in Alzheimer's disease: Integrating early diagnosis, personalized treatment, and prognostic modelling

Kale M, Wankhede N, Pawar R, Ballal S, Kumawat R, Goswami M, Khalid M, Taksande B, Upaganlawar A, Umekar M, Kopalli SR, Koppula S.

Ageing Res Rev. 2024 Nov;101:102497. doi: 10.1016/j.arr.2024.102497. Epub 2024 Sep 16.

Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2

Tumati S, Herrmann N, Perin J, Rosenberg PB, Lerner AJ, Mintzer J, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Shade D, Lanctôt KL.

Int Psychogeriatr. 2024 Dec;36(12):1232-1244. doi: 10.1017/S1041610224000711. Epub 2024 Sep 19.

Unveiling the theranostic potential of SPIONs in Alzheimer's disease management

Aminyavari S, Afshari AR, Ahmadi SS, Kesharwani P, Sanati M, Sahebkar A.

J Psychiatr Res. 2024 Nov;179:244-256. doi: 10.1016/j.jpsychires.2024.09.022. Epub 2024 Sep 20.

Amyloid related imaging abnormalities in the emergency setting

Czerminski J, Khatri S, Rao B.

Emerg Radiol. 2024 Dec;31(6):937-941. doi: 10.1007/s10140-024-02286-2. Epub 2024 Sep 27.

Public perceptions related to healthcare preparedness to anti-amyloid therapies for Alzheimer's Disease in Japan

Sato K, Niimi Y, Ihara R, Iwata A, Suzuki K, Nemoto K, Arai T, Higashi S, Igarashi A, Kasuga K, Awata S, Iwatsubo T.

Alzheimers Res Ther. 2024 Oct 3;16(1):205. doi: 10.1186/s13195-024-01568-8.

Functional Magnetic Resonance Imaging in Alzheimer's Disease Drug Trials: A Mini-Review

Alghamdi M, Braidy N.

J Alzheimers Dis. 2024;101(s1):S567-S578. doi: 10.3233/JAD-231276.

PET/CT/MRI in Clinical Trials of Alzheimer's Disease

Høilund-Carlsen PF, Alavi A, Barrio JR.

J Alzheimers Dis. 2024;101(s1):S579-S601. doi: 10.3233/JAD-240206.

Research Progress of Novel Inorganic Nanomaterials in the Diagnosis and Treatment of Alzheimer's Disease

Ding N, Lei Y, Hu Y, Wei J, Wang W, Zhang R, Cai F.

Neurol India. 2024 Sep 1;72(5):943-950. doi: 10.4103/neurol-india.Neurol-India-D-23-00592. Epub 2024 Oct 19.

Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta-analysis

McLaughlin J, Scotton WJ, Ryan NS, Hardy JA, Shoai M.

Alzheimers Dement. 2024 Dec;20(12):8673-8683. doi: 10.1002/alz.14314. Epub 2024 Oct 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias